Charter Oak Capital Management’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-444
Closed -$19K 253
2022
Q2
$19K Buy
444
+6
+1% +$261 ﹤0.01% 480
2022
Q1
$20K Buy
438
+7
+2% +$310 ﹤0.01% 511
2021
Q4
$21K Buy
431
+6
+1% +$284 ﹤0.01% 494
2021
Q3
$20K Buy
425
+5
+1% +$244 ﹤0.01% 455
2021
Q2
$20K Buy
420
+5
+1% +$239 ﹤0.01% 447
2021
Q1
$19K Buy
415
+5
+1% +$237 ﹤0.01% 443
2020
Q4
$19K Buy
+410
New +$18.6K ﹤0.01% 419

Other funds holding BME

Charter Oak Capital Management's BME Position: Q3 2022 in Review

Charter Oak Capital Management sold out of BlackRock Health Sciences Trust (BME) in Q3 2022, closing a stake of 444 shares — an estimated $19K sold.

Charter Oak Capital Management first reported a position in BME in Q4 2020 and held it in 7 quarters. The position peaked at $21K in Q4 2021. 62 funds tracked by Wall St. Rank hold BME as of Q3 2022.

  • Charter Oak Capital Management reported no remaining BlackRock Health Sciences Trust position as of Q3 2022 after selling out during the quarter.
  • Charter Oak Capital Management sold 444 BlackRock Health Sciences Trust shares in Q3 2022, an estimated $19K.
  • Charter Oak Capital Management first reported a position in BlackRock Health Sciences Trust in Q4 2020 and held it in 7 quarters.
  • Charter Oak Capital Management's BlackRock Health Sciences Trust position peaked at $21K in Q4 2021.
  • 62 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q3 2022.

Based on Charter Oak Capital Management's 13F filing for Q3 2022, filed 6 Dec 2022.